Bay Colony Advisory Group, Inc D Abb Vie Inc. Transaction History

Bay Colony Advisory Group, Inc D

$580 Million
Q2 2024

A detailed history of Bay Colony Advisory Group, Inc D transactions in Abb Vie Inc. stock. As of the latest transaction made, Bay Colony Advisory Group, Inc D holds 10,501 shares of ABBV stock, worth $1.85 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

10,501

Previous 10,517 0.15%

Holding current value

$1.85 Million

Previous $1.92 Million 5.95%

% of portfolio

0.31%

Previous 0.35%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	SELL	$154.79 - $180.76 $2,476 - $2,892	-16 Reduced 0.15%	10,501 $1.8 Million
Q1 2024 Apr 30, 2024	SELL	$159.82 - $182.1 $73,836 - $84,130	-462 Reduced 4.21%	10,517 $1.92 Million
Q4 2023 Jan 29, 2024	BUY	$137.6 - $154.97 $225,939 - $254,460	1,642 Added 17.59%	10,979 $1.7 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $494,950 - $572,978	-3,705 Reduced 28.41%	9,337 $1.39 Million
Q2 2023 Aug 11, 2023	BUY	$132.51 - $164.9 $71,687 - $89,210	541 Added 4.33%	13,042 $1.76 Million

Q1 2023 Apr 27, 2023	SELL	$144.61 - $166.54 $88,501 - $101,922	-612 Reduced 4.67%	12,501 $1.99 Million
Q4 2022 Feb 01, 2023	SELL	$138.31 - $165.87 $88,795 - $106,488	-642 Reduced 4.67%	13,113 $2.12 Million
Q3 2022 Oct 27, 2022	SELL	$134.21 - $153.93 $73,547 - $84,353	-548 Reduced 3.83%	13,755 $1.85 Million
Q2 2022 Aug 08, 2022	BUY	$137.62 - $174.96 $178,768 - $227,273	1,299 Added 9.99%	14,303 $2.05 Million
Q1 2022 Apr 28, 2022	SELL	$131.98 - $163.75 $525,940 - $652,543	-3,985 Reduced 23.46%	13,004 $2.11 Million
Q4 2021 Jan 28, 2022	SELL	$107.43 - $135.93 $48,665 - $61,576	-453 Reduced 2.6%	16,989 $2.3 Million
Q3 2021 Nov 02, 2021	BUY	$106.4 - $120.78 $12,448 - $14,131	117 Added 0.68%	17,442 $1.88 Million
Q2 2021 Jul 22, 2021	BUY	$105.21 - $117.21 $22,304 - $24,848	212 Added 1.24%	17,325 $1.95 Million
Q1 2021 May 13, 2021	BUY	$102.3 - $112.62 $262,808 - $289,320	2,569 Added 17.66%	17,113 $1.85 Million
Q4 2020 Feb 02, 2021	SELL	$80.49 - $108.67 $78,477 - $105,953	-975 Reduced 6.28%	14,544 $1.56 Million
Q3 2020 Nov 25, 2020	BUY	$85.91 - $100.83 $40,377 - $47,390	470 Added 3.12%	15,519 $1.36 Million
Q2 2020 Jul 23, 2020	SELL	$73.37 - $98.18 $222,311 - $297,485	-3,030 Reduced 16.76%	15,049 $1.48 Million
Q1 2020 Apr 17, 2020	BUY	$64.5 - $97.79 $245,035 - $371,504	3,799 Added 26.6%	18,079 $1.38 Million
Q4 2019 Jan 28, 2020	BUY	$72.13 - $90.25 $1.03 Million - $1.29 Million	14,280 New	14,280 $1.25 Million
Q4 2019 Jan 28, 2020	SELL	$72.13 - $90.25 $1.49 Million - $1.86 Million	-20,605 Closed	0 $0
Q3 2019 Oct 25, 2019	BUY	$62.98 - $75.72 $1.06 Million - $1.27 Million	16,784 Added 439.26%	20,605 $1.56 Million
Q2 2019 Jul 17, 2019	BUY	$65.7 - $83.98 $251,039 - $320,887	3,821 New	3,821 $278,000
Q3 2018 Nov 05, 2018	SELL	$88.91 - $98.84 $88,020 - $97,851	-990 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$89.78 - $106.23 $88,882 - $105,167	990 New	990 $92,000

Others Institutions Holding ABBV

# of Institutions

3,643

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.5M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $312B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bay Colony Advisory Group, Inc D, based on Form 13F filings with the SEC.

News

Stay updated on Bay Colony Advisory Group, Inc D with notifications on news.

Account

Bay Colony Advisory Group, Inc D Abb Vie Inc. Transaction History